Results 51 to 60 of about 14,201 (263)
Inter-observer variability (IOV) in radiotherapy contouring remains a significant source of uncertainty, especially for complex anatomical regions.
Polly Darby +5 more
doaj +1 more source
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Evolution of Radiotherapy: High-precision Radiotherapy [PDF]
Technological advances that have been achieved over the last two decades in the area of treatment planning and sophisticated and complicated hardware capabilities, such as computer-controlled treatments, multileaf collimators, and incorporating imaging ...
김용배, 서창옥
core +1 more source
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht +3 more
wiley +1 more source
Computerised tomography in radiotherapy planning [PDF]
Successful radiotherapy practice depends on the irradiation of tumours such that their destruction follows without unacceptable damage of the surrounding normal tissues. Until recently the accurate acquisition of data concerning the tumour anatomy lagged
Badcock, P.C. (Peter)
core +1 more source
Radiation Planning Index for dose distribution evaluation in stereotactic radiotherapy
AimThe aim of this study was to provide a parameter for treatment plan comparisons in clinical practice.Materials and Methods21 patients with brain tumours were selected for analysis. Two alternative treatment plans were calculated for each patient.
BYSTRZYCKA, Joanna; Department of Radiotherapy and Brachytherapy Planning, Maria Sklodowska Curie, Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Wybrzee Armii Krajowej 15, 44–101 Gliwice, Poland +3 more
core +1 more source
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends
This survey is performed to update knowledge about methods and trends in lung cancer radiotherapy. A significant development has been noticed in radiotherapeutic techniques, but also in the identification of clinical prognostic factors.
Maciejczyk, Adam; Radiotherapy Department, Lower Silesian Centre of Oncology, Wrocław, Poland +2 more
core +1 more source
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel +4 more
wiley +1 more source
Bridging the proton gap: A proton therapy consultation service for Canadian radiation oncologists
Purpose: Canada is the only G7 country without a clinical proton beam therapy (PBT) facility. Patients can access publicly funded PBT through provincial out-of-country approval programs.
Inhwa Kim +10 more
doaj +1 more source

